Cargando…

Pathophysiological Concepts and Treatment of Camptocormia

Camptocormia is a disabling pathological, non-fixed, forward bending of the trunk. The clinical definition using only the bending angle is insufficient; it should include the subjectively perceived inability to stand upright, occurrence of back pain, typical individual complaints, and need for walki...

Descripción completa

Detalles Bibliográficos
Autores principales: Margraf, N.G., Wrede, A., Deuschl, G., Schulz-Schaeffer, W.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008234/
https://www.ncbi.nlm.nih.gov/pubmed/27314757
http://dx.doi.org/10.3233/JPD-160836
_version_ 1782451333525143552
author Margraf, N.G.
Wrede, A.
Deuschl, G.
Schulz-Schaeffer, W.J.
author_facet Margraf, N.G.
Wrede, A.
Deuschl, G.
Schulz-Schaeffer, W.J.
author_sort Margraf, N.G.
collection PubMed
description Camptocormia is a disabling pathological, non-fixed, forward bending of the trunk. The clinical definition using only the bending angle is insufficient; it should include the subjectively perceived inability to stand upright, occurrence of back pain, typical individual complaints, and need for walking aids and compensatory signs (e.g. back-swept wing sign). Due to the heterogeneous etiologies of camptocormia a broad diagnostic approach is necessary. Camptocormia is most frequently encountered in movement disorders (PD and dystonia) and muscles diseases (myositis and myopathy, mainly facio-scapulo-humeral muscular dystrophy (FSHD)). The main diagnostic aim is to discover the etiology by looking for signs of the underlying disease in the neurological examination, EMG, muscle MRI and possibly biopsy. PD and probably myositic camptocormia can be divided into an acute and a chronic stage according to the duration of camptocormia and the findings in the short time inversion recovery (STIR) and T1 sequences of paravertebral muscle MRI. There is no established treatment of camptocormia resulting from any etiology. Case series suggest that deep brain stimulation (DBS) of the subthalamic nucleus (STN-DBS) is effective in the acute but not the chronic stage of PD camptocormia. In chronic stages with degenerated muscles, treatment options are limited to orthoses, walking aids, physiotherapy and pain therapy. In acute myositic camptocormia an escalation strategy with different immunosuppressive drugs is recommended. In dystonic camptocormia, as in dystonia in general, case reports have shown botulinum toxin and DBS of the globus pallidus internus (GPi-DBS) to be effective. Camptocormia in connection with primary myopathies should be treated according to the underlying illness.
format Online
Article
Text
id pubmed-5008234
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-50082342016-09-09 Pathophysiological Concepts and Treatment of Camptocormia Margraf, N.G. Wrede, A. Deuschl, G. Schulz-Schaeffer, W.J. J Parkinsons Dis Review Camptocormia is a disabling pathological, non-fixed, forward bending of the trunk. The clinical definition using only the bending angle is insufficient; it should include the subjectively perceived inability to stand upright, occurrence of back pain, typical individual complaints, and need for walking aids and compensatory signs (e.g. back-swept wing sign). Due to the heterogeneous etiologies of camptocormia a broad diagnostic approach is necessary. Camptocormia is most frequently encountered in movement disorders (PD and dystonia) and muscles diseases (myositis and myopathy, mainly facio-scapulo-humeral muscular dystrophy (FSHD)). The main diagnostic aim is to discover the etiology by looking for signs of the underlying disease in the neurological examination, EMG, muscle MRI and possibly biopsy. PD and probably myositic camptocormia can be divided into an acute and a chronic stage according to the duration of camptocormia and the findings in the short time inversion recovery (STIR) and T1 sequences of paravertebral muscle MRI. There is no established treatment of camptocormia resulting from any etiology. Case series suggest that deep brain stimulation (DBS) of the subthalamic nucleus (STN-DBS) is effective in the acute but not the chronic stage of PD camptocormia. In chronic stages with degenerated muscles, treatment options are limited to orthoses, walking aids, physiotherapy and pain therapy. In acute myositic camptocormia an escalation strategy with different immunosuppressive drugs is recommended. In dystonic camptocormia, as in dystonia in general, case reports have shown botulinum toxin and DBS of the globus pallidus internus (GPi-DBS) to be effective. Camptocormia in connection with primary myopathies should be treated according to the underlying illness. IOS Press 2016-08-20 /pmc/articles/PMC5008234/ /pubmed/27314757 http://dx.doi.org/10.3233/JPD-160836 Text en IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Margraf, N.G.
Wrede, A.
Deuschl, G.
Schulz-Schaeffer, W.J.
Pathophysiological Concepts and Treatment of Camptocormia
title Pathophysiological Concepts and Treatment of Camptocormia
title_full Pathophysiological Concepts and Treatment of Camptocormia
title_fullStr Pathophysiological Concepts and Treatment of Camptocormia
title_full_unstemmed Pathophysiological Concepts and Treatment of Camptocormia
title_short Pathophysiological Concepts and Treatment of Camptocormia
title_sort pathophysiological concepts and treatment of camptocormia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008234/
https://www.ncbi.nlm.nih.gov/pubmed/27314757
http://dx.doi.org/10.3233/JPD-160836
work_keys_str_mv AT margrafng pathophysiologicalconceptsandtreatmentofcamptocormia
AT wredea pathophysiologicalconceptsandtreatmentofcamptocormia
AT deuschlg pathophysiologicalconceptsandtreatmentofcamptocormia
AT schulzschaefferwj pathophysiologicalconceptsandtreatmentofcamptocormia